SEMGLEE 100 [iU]/mL
insulin glargine-yfgn · INJECTION, SOLUTION · Biocon Biologics Inc.
No Recall HistoryCurrently in Shortage
Plain English
SEMGLEE is a injection, solution containing insulin glargine-yfgn at 100 [iU]/mL, taken subcutaneous. Manufactured by Biocon Biologics Inc..
Key Facts
- Brand Name
- SEMGLEE
- Generic Name
- insulin glargine-yfgn
- NDC Code (Product)
83257-012- Manufacturer
- Biocon Biologics Inc.
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761201
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 07/28/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is SEMGLEE used for?
SEMGLEE contains insulin glargine-yfgn. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is SEMGLEE a controlled substance?
SEMGLEE is not classified as a controlled substance by the DEA.
What is the generic name for SEMGLEE?
The generic name for SEMGLEE is insulin glargine-yfgn. There are 4 other brand versions of insulin glargine-yfgn.
What is the NDC code for SEMGLEE 100 [iU]/mL?
The NDC (National Drug Code) for SEMGLEE 100 [iU]/mL is 83257-012, listed by Biocon Biologics Inc..